Sudden cardiac death prevention: antiarrhythmic drugs and the implantable cardioverter-defibrillator.
Domanski
M J
MJ
Clinical Trials Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892, USA.
D000206:Actuarial Analysis; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000401:mortality / Q000628:therapy; D003131:Combined Modality Therapy; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D006801:Humans; D011322:Primary Prevention; D015996:Survival Rate